View in EDS

445TiPComprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy.

Saved in:
Bibliographic Details
Title: 445TiPComprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy.
Authors: Krämer, A1 (AUTHOR), Losa, F2 (AUTHOR), Gay, L M3 (AUTHOR), Page, D R4 (AUTHOR), Foser, S4 (AUTHOR), Mughal, T I5 (AUTHOR), Ross, J S3 (AUTHOR), Baciarello, G6 (AUTHOR), Mileshkin, L R7 (AUTHOR), Osborne, S8 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy279.432